Stocklytics Platform
GOVX
GeoVax Labs
GOVXW8
$0.140.00%$0.00
Penny Stock
GOVX
GOVXW8

$0.14

0.00%

Performance History

Chart placeholder
Key Stats
Open$0.14
Prev. Close$0.14
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$0.00
PE Ratio-
LOWHIGH
Day Range0.13
0.16
52 Week Range0.02
34.93
Ratios
Revenue-
EBITDA Margin %-
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About GeoVax Labs (GOVXW)

GeoVax Labs, Inc. (GOVXW) is a biotechnology company that specializes in the development and commercialization of vaccines for infectious diseases. The company is focused on the research and development of preventive and therapeutic vaccines to address the global health challenges posed by viruses such as HIV, Zika, Ebola, and others. GeoVax Labs has a strong track record of innovation and has developed novel vaccine platforms that have shown promise in preclinical and clinical trials.
The stock price history of GeoVax Labs, Inc. (GOVXW) has been volatile in recent years, reflecting the uncertainty and risks associated with the biotechnology sector. However, the company's groundbreaking research and development efforts have attracted the attention of investors who are interested in the potential of its vaccine candidates. GeoVax Labs has made significant progress in advancing its pipeline, and positive news and clinical trial results have often led to an increase in the stock price.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add GeoVax Labs to watchlist

Keep an eye on GeoVax Labs

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the market capitalization of GeoVax Labs (GOVXW)?

GeoVax Labs (GOVXW) has a market capitalization of $0. The average daily trading volume is 0.13, indicating the stock's liquidity and investor engagement.
help

What is GeoVax Labs's (GOVXW) price per share?

The current price per share for GeoVax Labs (GOVXW) is $0.14. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for GeoVax Labs (GOVXW)?

For GeoVax Labs (GOVXW), the 52-week high is $34.93, which is 24.16K% from the current price. The 52-week low is $0.02, the current price is 526.09% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is GeoVax Labs (GOVXW) a growth stock?

GeoVax Labs (GOVXW) has shown an average price growth of -6.8% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying GeoVax Labs as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is GeoVax Labs (GOVXW) stock price performance year to date (YTD)?

As of the latest data, GeoVax Labs (GOVXW) has a year-to-date price change of 188.58%. Over the past month, the stock has experienced a price change of 20%. Over the last three months, the change has been -64.86%. Over the past six months, the figure is 140%.
help

Is GeoVax Labs (GOVXW) a profitable company?

GeoVax Labs (GOVXW) has a net income of -$25.97M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.68K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$26.74M. Furthermore, the EBITDA is -$27.16M.

News

Take Your Investments to a Whole New Level